Palvella Therapeutics, Inc. (PVLA) financial statements and ratios from SEC XBRL: revenue $42.81M (latest fiscal year), net margin -57.3%, revenue growth -100.0% YoY. Income statement, balance sheet, cash flow, and valuation. First-party data.
| Revenue (latest FY) | $42.81M |
| Net Margin | -57.3% |
| Revenue Growth (YoY) | -100.0% |
| EPS Growth (YoY) | -76.3% |
| FCF Growth (YoY) | -72.6% |
| Price / Book | 9.41 |
| Price / Sales | 104.21 |
| Industry P/E (Pharmaceutical Products) | 17.2 |
| Sector P/E (Healthcare) | 21.7 |
PVLA overview · PVLA earnings · PVLA KPIs · PVLA documents · PVLA ownership · PVLA peers
Data sourced from U.S. SEC EDGAR XBRL filings. Not personalized investment advice.